120 related articles for article (PubMed ID: 2069095)
21. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile.
Morgan GJ; Kaine J; DeLapp R; Palmer R
J Clin Gastroenterol; 2001 Apr; 32(4):310-4. PubMed ID: 11276273
[TBL] [Abstract][Full Text] [Related]
22. Lymph distribution of different non-steroidal anti-inflammatory drugs assessed by microsurgical cannulation of the thoracic duct in rat.
Ionac M; Oelkers R; Brune K; Geisslinger G; Bordos D
Rom J Intern Med; 1996; 34(3-4):239-51. PubMed ID: 9167225
[TBL] [Abstract][Full Text] [Related]
23. Concentration-response relationships for three nonsteroidal anti-inflammatory drugs in the rat intestine.
Ford J; Houston JB
Hum Exp Toxicol; 1995 Jul; 14(7):573-9. PubMed ID: 7576817
[TBL] [Abstract][Full Text] [Related]
24. Grapefruit juice potentiates the anti-inflammatory effects of diclofenac on the carrageenan-induced rat's paw oedema.
Mahgoub AA
Pharmacol Res; 2002 Jan; 45(1):1-4. PubMed ID: 11820853
[TBL] [Abstract][Full Text] [Related]
25. Quantitative characterization of a repeated acute joint inflammation model in rats.
Peter-Szabo M; Kekesi G; Nagy E; Sziver E; Benedek G; Horvath G
Clin Exp Pharmacol Physiol; 2007; 34(5-6):520-6. PubMed ID: 17439426
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of the gastrointestinal tolerance of diclofenac and aceclofenac.
Rimbau V; Fernandez MF; Guirao I; Torralba A; Izquierdo E
Farmaco Prat; 1988 Jan; 43(1):19-26. PubMed ID: 3260195
[No Abstract] [Full Text] [Related]
27. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
28. Alkyl ester prodrugs for improved topical delivery of ibuprofen.
Bansal AK; Khar RK; Dubey R; Sharma AK
Indian J Exp Biol; 2001 Mar; 39(3):280-3. PubMed ID: 11495290
[TBL] [Abstract][Full Text] [Related]
29. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
31. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
32. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats.
Sümen G; Cimşit M; Eroglu L
Eur J Pharmacol; 2001 Nov; 431(2):265-8. PubMed ID: 11728435
[TBL] [Abstract][Full Text] [Related]
33. The unique pharmacologic profile of nabumetone.
Blower PR
J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
[TBL] [Abstract][Full Text] [Related]
34. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA; Langtry HD; Buckley MM
Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs.
Chan FK; Sung JJ; Ching JY; Wu JC; Lee YT; Leung WK; Hui Y; Chan LY; Lai AC; Chung SC
Aliment Pharmacol Ther; 2001 Jan; 15(1):19-24. PubMed ID: 11136274
[TBL] [Abstract][Full Text] [Related]
36. A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.
Gigler G; Kiszelly E; Tömpe P; Kovács G; Gadó K
Agents Actions Suppl; 1991; 32():39-43. PubMed ID: 1906236
[TBL] [Abstract][Full Text] [Related]
37. Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol.
Bentkover JD; Baker AM; Kaplan H
Pharmacoeconomics; 1994 Apr; 5(4):335-42. PubMed ID: 10160575
[TBL] [Abstract][Full Text] [Related]
38. Benzyl ester prodrug of ibuprofen: pharmacological and toxicological profile.
Bansal AK; Khar RK; Dubey R; Sharma AK
Boll Chim Farm; 2001; 140(2):79-82. PubMed ID: 11417391
[TBL] [Abstract][Full Text] [Related]
39. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
Boyle EA; Freeman PC; Mangan FR; Thomson MJ
J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
[TBL] [Abstract][Full Text] [Related]
40. Aceclofenac topical dosage forms: in vitro and in vivo characterization.
Dua K; Pabreja K; Ramana MV
Acta Pharm; 2010 Dec; 60(4):467-78. PubMed ID: 21169138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]